IMR Press / CEOG / Volume 8 / Issue 2 / pii/1634262082643-1816473944

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Amniotic fluid β2- microglobulin (β2-m) as an index of fetal maturity

Show Less
1 Department of Obstetrics and Gynecology, University of Ferrara (Italy)
2 Department of Nephrology, Arcispedale, “S. Anna”, Ferrara (Italy)
3 Laboratory of Clinical Chemistry and Microbiology, Arcispedale “S. Anna”, Ferrara (Italy)
Clin. Exp. Obstet. Gynecol. 1981, 8(2), 66–69;
Published: 10 June 1981
Abstract

 

Amniotic fluid β2 microglobulin (β2-m) levels were measured by radioimmunoassay in 78 pregnant women between the 14th and the 42nd week of gestation. 62 were healthy subjects, while eight were affected by EPH gestosis, seven by diabetes (cl. B-F) associated with Rh immunization in one case, one by hydramnios. There was no significant correlation either between β2-m and creatinine (n = 18), or between β2-m and lecithin sphingomyelin ratio (L/S) (n = 16), although low concentrations of β2-m were usually observed after the 35th week of gestation. It is noteworthy that only in one case out of seven with amniotic levels less than 5 microgram/ml L/S ratio was less than 2.
Share
Back to top